有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Idarubicin hydrochloride;NSC-256439;IMI-30;DMDR;Idamycin;Zavedos
Chemical Name (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride;(7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione hydrochloride;4-Demethoxydaunomycin hydrochloride;4-Demethoxydaunorubicin hydrochloride
CAS 58957-92-9
Related CAS
Formula C26H28ClNO9
Structure
Formula Weight 533.96736
Stage 上市-1990
Company Pfizer (Originator)
Activity/Mechanism Oncolytic Drugs, Anthracyclines
Syn. Route 2
Route 1
the condensation of chiral tetraline (i) with phthalic anhydride (ii) by means of alcl3 at 180 c gives the naphthacenedione (iii), which is ketalized at the acetyl group with ethylene glycol and p-toluenesulfonic acid yielding the dioxolane (iv). the hydroxylation of (iv) with br2 and aibn in ccl4/chcl3 affords the 4-demethoxy-7-epidaunomycinone (v), which is isomerized with tfa yielding 4-demethoxydaunomycinone (vi) . the condensation of (vi) with the acylated hexopyranosyl chloride (vii) by means of cf3so3ag of br2hg affords the trifluoroacetylated 4-demethoxydaunomycin (viii), which is finally treated with naoh in order to eliminate the trifluoroacetyl groups
List of intermediates No.
(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-6-sulfo-1,2,3,4,4a,9,10,10a-octahydro-1-phenanthrenecarboxylic acid
2-isopropoxy-1-ethanol (ii)
(3s,6r,7s,8s)-11-(benzyloxy)-3,7-bis[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8-tetramethyl-5-oxoundecanoic acid (i)
methyl (3s,6r,7s,8s)-11-(benzyloxy)-3,7-bis[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8-tetramethyl-5-oxoundecanoate (iii)
methyl (3s,6r,7s,8s)-3,7-bis[[tert-butyl(dimethyl)silyl]oxy]-11-hydroxy-4,4,6,8-tetramethyl-5-oxoundecanoate (iv)
methyl (3s,6r,7s,8s)-3,7-bis[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8-tetramethyl-11-[(2-nitrophenyl)selanyl]-5-oxoundecanoate (v)
methyl (3s,6r,7s,8s)-3,7-bis[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8-tetramethyl-5-oxo-10-undecenoate (vi)
1,2-dimethyl-1h-benzimidazole-5-carbaldehyde (vii)
(1s,5r)-4-acetyl-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione (viii)
Reference 1:
    arcamone, f.; et al.; synthesis and antitumour activity of new daunorubicin and adriamycin analogues. experientia 1978, 34, 1255.
Reference 2:
    bernardi, l.; arcamone, f.; patelli, b.; di marco, a. (pharmacia corp.); daunomycin analogues, their preparation and use. de 2525633; us 4046878 .

Route 2
the reaction of daunomycinone (ix) with alcl3 in dichloromethane gives 4-demethyldaunomycinone (x), which is ketalized with ethylene glycol as before yielding the dioxolane (xi). the selective sulfonation of (xi) with tscl, diea and dmap in pyridine affords the 4-tosyloxy derivative (xii), which is treated with 4-methoxybenzylamine (xiii) in pyridine providing the secondary benzylamine (xiv). elimination of the benzyl protecting group of (xiv) with tfa gives 4-amino-4-demethoxydaunomycinone ethylene ketal (xv), which is deaminated by reaction with tfa, nano2 and h3po2 to give 4-demethoxydaunomycinone (xvi). finally, this compound is submitted to fermentation with streptomyces peucetius corneus, s. peucetius caesius, s. caeruleus, s. peucetius, s. coeruleorubidus, and other chemical or radio-induced mutants thereof.
List of intermediates No.
(1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-6-sulfo-1,2,3,4,4a,9,10,10a-octahydro-1-phenanthrenecarboxylic acid
(3s,5r,8r,9s,10s,13r,17r)-17-(3-furyl)-10,13-dimethylhexadecahydro-14h-cyclopenta[a]phenanthrene-3,14-diol (xiii)
methyl (3s,6r,7s,8s)-3,7-bis[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8-tetramethyl-5-oxo-10-undecenoate (xvi)
(1s,5r)-4-[(3s)-3-(1,2-dimethyl-1h-benzimidazol-5-yl)-3-hydroxypropanoyl]-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione (ix)
(1s,5r)-4-[(3s)-3-[[tert-butyl(dimethyl)silyl]oxy]-3-(1,2-dimethyl-1h-benzimidazol-5-yl)propanoyl]-10,10-dimethyl-3lambda(6)-thia-4-azatricyclo[5.2.1.0(1,5)]decane-3,3-dione (x)
(3s)-3-[[tert-butyl(dimethyl)silyl]oxy]-3-(1,2-dimethyl-1h-benzimidazol-5-yl)propanal (xi)
5-((1s,3z)-1-[[tert-butyl(dimethyl)silyl]oxy]-4-iodo-3-pentenyl)-1,2-dimethyl-1h-benzimidazole; tert-butyl(dimethyl)silyl (1s,3z)-1-(1,2-dimethyl-1h-benzimidazol-5-yl)-4-iodo-3-pentenyl ether (xii)
methyl (3s,6r,7s,8s)-10-(9-borabicyclo[3.3.1]non-9-yl)-3,7-bis[[tert-butyl(dimethyl)silyl]oxy]-4,4,6,8-tetramethyl-5-oxodecanoate (xiv)
methyl (2r,5r,6s,7s,11z,14s)-2,6,14-tris[[tert-butyl(dimethyl)silyl]oxy]-14-(1,2-dimethyl-1h-benzimidazol-5-yl)-3,3,5,7,11-pentamethyl-4-oxo-11-tetradecenoate (xv)
Reference 1:
    francalanci, f.; martinengo, t.; de bernardinis, s.; cabri, w. (pharmacia corp.); process for the preparation of 4-demethoxydaunomycinone, the aglycone of 4-demethoxy-daunorubicin. ep 0328399 .
Reference 2:
    mitscher, l.a.; lednicer, d. (pharmacia corp.); biosynthesis of simplified anthracyclines. us 4471052 .

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名依达比星;英文名Idarubicin hydrochloride;NSC-256439;IMI-30;DMDR;Idamycin;Zavedos;CAS[58957-92-9]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
呋虫胺和烯啶虫胺继续扩作
华南地区环氧丙烷市场稳定
华东地区丁二烯市场盘整
丰山集团正式挂牌,发行首日秒封
苯胺跌势难改
损失或超6千万!这家上市公司被
山东地区环氧丙烷市场稳定
丙炔氟草胺领军“其他PPO抑制
华北地区醋酸价格整体上调
吡丙醚和氟啶虫酰胺继续扩作
红太阳子公司南京生化完成增资工
嘧菌胺获欧盟批准开展再评审,但
新型“超分子纳米囊”可减少农药
PTA 回调为主
醋酸市场供需平衡
华中地区甲苯行情暂稳
东北地区甲苯行情暂稳
新增一家毒氟磷制剂登记企业
装置集中检修 丁酮强势上涨难持
关于农药登记有关行政许可办理系
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明